Login / Signup

An optimized procedure for Luminex-based human platelet antigen-specific antibody screening and identification (PakLx assay) with a cost-effective approach and improved sensitivity.

Gerald BertrandJulien GriffonVirginie Renac
Published in: Vox sanguinis (2023)
In the event of an inconclusive result with this optimized protocol (e.g., incomplete panel of positive Luminex beads), we recommend testing the sample with an alternative protocol (e.g., MAIPA or the original PakLx protocol).
Keyphrases
  • randomized controlled trial
  • endothelial cells
  • high throughput
  • induced pluripotent stem cells